The rapid rise of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has fundamentally altered the clinical landscape…
Read More »The rapid rise of Glucagon-Like Peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has fundamentally altered the clinical landscape…
Read More »